SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-14 |
| Reported value | $191,085,715 |
| Positions | 29 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| PLAINS GP HOLDINGS LP-CL | PAGP | COMM | $30,880,177 | 1,272,360 |
| ACHIEVE LIFE SCIENCES INC | ACHV | COMM | $26,342,138 | 4,034,018 |
| CORCEPT THERAPEUTICS INC | CORT | COMM | $11,868,588 | 136,499 |
| PHATHOM PHARMACEUTICALS I | PHAT | COMM | $11,396,384 | 1,050,358 |
| DELCATH SYSTEMS INC | DCTH | COMM | $10,971,681 | 871,460 |
| MILESTONE PHARMACEUTICALS | MIST | COMM | $9,955,651 | 7,429,590 |
| COMPASS PATHWAYS PLC | CMPS | ADRS | $8,109,167 | 573,086 |
| KYVERNA THERAPEUTICS INC | KYTX | COMM | $7,869,294 | 883,198 |
| ARTIVA BIOTHERAPEUTICS IN | ARTV | COMM | $6,755,429 | 696,436 |
| ABEONA THERAPEUTICS INC | ABEO | COMM | $6,075,373 | 983,070 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.